Stuglik Brian M

Avg. Two Year Performance

(83%) Avg. Purchase Return
(35%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(30%)(54%)(57%)(83%)(83%)
Purchase Success Rate0 of 10 of 10 of 10 of 10 of 1
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 20 of 20 of 20 of 20 of 2

Puma Biotechnology, Inc.

Other » Other

Director:

Holdings: 58.96K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Verastem, Inc.

Drugs » Biotechnology

Director:

Holdings: 89.64K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--